Most miRNAs have implications in APP processing, neuroinflammation and tau phosphorylation, whilst others are involved in more than one of these processes, suggesting miRNAs may provide good therapeutic targets for interventions or treating a range of biological deformities associated with AD. Here, APP is linked to Alzheimer disease.